23andMe Holding Co.

Competitive intelligence and market positioning for 23andMe Holding Co. across 1 market research report.

1 Reports
1 Industries
Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics

Reports Featuring 23andMe Holding Co.

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

Explore More Companies

Browse competitive intelligence on all key market players across our research coverage.

View all companies